2-219539616-C-G

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_024536.6(CHPF):​c.2095G>C​(p.Glu699Gln) variant causes a missense change. The variant allele was found at a frequency of 0.000222 in 1,613,794 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. E699E) has been classified as Benign.

Frequency

Genomes: 𝑓 0.000099 ( 0 hom., cov: 34)
Exomes 𝑓: 0.00023 ( 0 hom. )

Consequence

CHPF
NM_024536.6 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.00
Variant links:
Genes affected
CHPF (HGNC:24291): (chondroitin polymerizing factor) Enables N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity and glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity. Involved in chondroitin sulfate biosynthetic process. Predicted to be located in Golgi membrane. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2505492).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CHPFNM_024536.6 linkc.2095G>C p.Glu699Gln missense_variant Exon 4 of 4 ENST00000243776.11 NP_078812.3 Q8IZ52-1
CHPFNM_001195731.2 linkc.1609G>C p.Glu537Gln missense_variant Exon 4 of 4 NP_001182660.2 Q8IZ52-4
CHPFXM_011511838.4 linkc.1222G>C p.Glu408Gln missense_variant Exon 3 of 3 XP_011510140.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CHPFENST00000243776.11 linkc.2095G>C p.Glu699Gln missense_variant Exon 4 of 4 1 NM_024536.6 ENSP00000243776.6 Q8IZ52-1

Frequencies

GnomAD3 genomes
AF:
0.0000985
AC:
15
AN:
152248
Hom.:
0
Cov.:
34
show subpopulations
Gnomad AFR
AF:
0.0000482
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000654
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000176
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.000132
AC:
33
AN:
249868
Hom.:
0
AF XY:
0.000111
AC XY:
15
AN XY:
135338
show subpopulations
Gnomad AFR exome
AF:
0.0000623
Gnomad AMR exome
AF:
0.000116
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000109
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000213
Gnomad OTH exome
AF:
0.000328
GnomAD4 exome
AF:
0.000235
AC:
343
AN:
1461546
Hom.:
0
Cov.:
30
AF XY:
0.000224
AC XY:
163
AN XY:
727112
show subpopulations
Gnomad4 AFR exome
AF:
0.0000896
Gnomad4 AMR exome
AF:
0.0000894
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.000328
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.0000188
Gnomad4 NFE exome
AF:
0.000279
Gnomad4 OTH exome
AF:
0.000199
GnomAD4 genome
AF:
0.0000985
AC:
15
AN:
152248
Hom.:
0
Cov.:
34
AF XY:
0.0000538
AC XY:
4
AN XY:
74386
show subpopulations
Gnomad4 AFR
AF:
0.0000482
Gnomad4 AMR
AF:
0.0000654
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000176
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000727
Hom.:
0
Bravo
AF:
0.000151
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000233
AC:
2
ExAC
AF:
0.0000989
AC:
12
EpiCase
AF:
0.000109
EpiControl
AF:
0.000296

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Sep 29, 2023
Ambry Genetics
Significance: Uncertain significance
Review Status: criteria provided, single submitter
Collection Method: clinical testing

The c.2095G>C (p.E699Q) alteration is located in exon 4 (coding exon 4) of the CHPF gene. This alteration results from a G to C substitution at nucleotide position 2095, causing the glutamic acid (E) at amino acid position 699 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.36
T
BayesDel_noAF
Benign
-0.46
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Benign
0.092
T;.
Eigen
Uncertain
0.58
Eigen_PC
Uncertain
0.56
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Benign
0.83
T;T
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.25
T;T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
1.9
L;.
PrimateAI
Benign
0.47
T
PROVEAN
Benign
-0.91
N;N
REVEL
Benign
0.17
Sift
Benign
0.13
T;T
Sift4G
Uncertain
0.018
D;D
Polyphen
0.98
D;.
Vest4
0.33
MVP
0.61
MPC
0.55
ClinPred
0.078
T
GERP RS
4.6
Varity_R
0.19
gMVP
0.45

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs149014949; hg19: chr2-220404338; COSMIC: COSV60533768; COSMIC: COSV60533768; API